Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Henan University of Science and TechnologyActive in the last 2 years

Yanhui Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3896-916X; OpenAlex author ID A5110683374. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2016: 2 papers · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 3 papers

Papers 9

  1. PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC. Co-author DOI 10.1038/s41598-025-09591-x↗
  2. Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment. Last author DOI 10.1186/s12944-024-02426-0↗
  3. PSMD11 and PSMD14 may serve as novel biomarkers for the prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2025.1555649↗
  4. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effec… Co-author DOI 10.1038/s41392-020-0144-8↗
  5. Analysis of the autophagy gene expression profile of pancreatic cancer based on autophagy-related protein microtubule-associated protein 1A/1B-light chain 3. Co-author DOI 10.3748/wjg.v25.i17.2086↗
  6. SIRT1 promotes the proliferation and metastasis of human pancreatic cancer cells. Last author DOI 10.1177/1010428317691180↗
  7. Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer. Co-author DOI 10.3748/wjg.v23.i40.7232↗
  8. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2016.05.016↗
  9. Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms17060799↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanyan Zhang · 1 shared paper, 2025 · strength 0.30
  2. Chi Zhang · 1 shared paper, 2025 · strength 0.24
  3. Huahao Fan · 1 shared paper, 2025 · strength 0.24
  4. Hua Fan · 1 shared paper, 2025 · strength 0.24
  5. Jiangbo Liu · 2 shared papers, 2017–2019 · strength 0.20
  6. He Ren · 2 shared papers, 2016–2020 · strength 0.15
  7. Shengyu Yang · 2 shared papers, 2016–2020 · strength 0.15
  8. Xiuchao Wang · 2 shared papers, 2016–2020 · strength 0.15
  9. Jihui Hao · 2 shared papers, 2016–2020 · strength 0.15
  10. Yuxiang Zhang · 1 shared paper, 2019 · strength 0.11
  11. Hua Fan · 1 shared paper, 2019 · strength 0.11
  12. Mingxiao Lang · 2 shared papers, 2016 · strength 0.11
  13. Chongbiao Huang · 2 shared papers, 2016 · strength 0.11
  14. Xin Li · 1 shared paper, 2020 · strength 0.10
  15. Liangliang Lei · 1 shared paper, 2017 · strength 0.09
  16. Jianguang Jin · 1 shared paper, 2017 · strength 0.09
  17. Shuijun Zhang · 1 shared paper, 2017 · strength 0.09
  18. Na Li · 1 shared paper, 2016 · strength 0.05
  19. Yu Xu · 1 shared paper, 2016 · strength 0.05
  20. Jie Dong · 1 shared paper, 2016 · strength 0.05
  21. Zengxun Li · 1 shared paper, 2016 · strength 0.05
  22. Wenna Jiang · 1 shared paper, 2016 · strength 0.05
  23. Ming Yu · 1 shared paper, 2016 · strength 0.05
  24. He Ren · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.